Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ESMO Open|December 25, 2021
Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study)S Suppadungsuk, W Phitakwatchara, T Reungwetwattana, et al.
Oncotargets and Therapy|October 26, 2017
Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai populationN Trachu, E Sirachainan, N Larbcharoensub, et al.
BMC Cancer|February 12, 2024
Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancerT Thamrongjirapat, D Muntham, P Incharoen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA studyS Lu, M-J Ahn, T Reungwetwattana, et al.
ESMO Open|June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working groupH H Loong, T Shimizu, A Prawira, et al.
ESMO Open|November 30, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancerS-H Lee, J Menis, T M Kim, et al.
Pageof 1